[{"address1": "200 Arsenal Yards Boulevard", "address2": "Suite 230", "city": "Watertown", "state": "MA", "zip": "02472", "country": "United States", "phone": "857 285 5300", "website": "https://www.kymeratx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase II clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis; STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases and fibrosis; and MDM2 program to treat hematological malignancies and solid tumors. The company develops STAT6, a Type 2 inflammation in allergic diseases; and TYK2, a treatment for inflammatory bowel disease, psoriasis, psoriatic arthritis, and lupus. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Bruce L. Booth DPHIL, Ph.D.", "age": 50, "title": "Co-Founder & Independent Chairman", "yearBorn": 1974, "fiscalYear": 2023, "totalPay": 75000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Nello  Mainolfi M.D., Ph.D.", "age": 45, "title": "Co-Founder, President, CEO & Director", "yearBorn": 1979, "fiscalYear": 2023, "totalPay": 1075600, "exercisedValue": 457971, "unexercisedValue": 20455824}, {"maxAge": 1, "name": "Mr. Bruce N. Jacobs CFA", "title": "Chief Financial Officer", "fiscalYear": 2023, "totalPay": 671200, "exercisedValue": 249766, "unexercisedValue": 5641756}, {"maxAge": 1, "name": "Dr. Jeremy G. Chadwick Ph.D.", "age": 61, "title": "Chief Operating Officer", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 614498, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Ellen V. Chiniara Esq., J.D.", "age": 65, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 640345, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jared A. Gollob M.D.", "age": 59, "title": "Chief Medical Officer", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 723600, "exercisedValue": 0, "unexercisedValue": 4995031}, {"maxAge": 1, "name": "Ms. Karen  Weisbach", "title": "Head of People & Culture", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Juliet  Williams B.A Ph.D.", "title": "Head of Research", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 8, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 30.25, "open": 30.2, "dayLow": 29.16, "dayHigh": 31.49, "regularMarketPreviousClose": 30.25, "regularMarketOpen": 30.2, "regularMarketDayLow": 29.16, "regularMarketDayHigh": 31.49, "payoutRatio": 0.0, "forwardPE": -10.080386, "volume": 2130649, "regularMarketVolume": 2130649, "averageVolume": 509728, "averageVolume10days": 608070, "averageDailyVolume10Day": 608070, "bid": 31.18, "ask": 31.46, "bidSize": 1, "askSize": 1, "marketCap": 2035997568, "fiftyTwoWeekLow": 29.16, "fiftyTwoWeekHigh": 53.27, "priceToSalesTrailing12Months": 43.25284, "fiftyDayAverage": 39.3404, "twoHundredDayAverage": 41.6563, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1635015680, "profitMargins": 0.0, "floatShares": 42817019, "sharesOutstanding": 64944100, "sharesShort": 7339095, "sharesShortPriorMonth": 8352487, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.113299996, "heldPercentInsiders": 0.02491, "heldPercentInstitutions": 1.09808, "shortRatio": 14.41, "shortPercentOfFloat": 0.1265, "impliedSharesOutstanding": 64944100, "bookValue": 12.877, "priceToBook": 2.4345734, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -223858000, "trailingEps": -2.98, "forwardEps": -3.11, "enterpriseToRevenue": 34.734, "enterpriseToEbitda": -6.557, "52WeekChange": -0.28990608, "SandP52WeekChange": 0.14239466, "quoteType": "EQUITY", "currentPrice": 31.35, "targetHighPrice": 97.0, "targetLowPrice": 41.0, "targetMeanPrice": 58.36842, "targetMedianPrice": 56.0, "recommendationMean": 1.55, "recommendationKey": "buy", "numberOfAnalystOpinions": 19, "totalCash": 488744000, "totalCashPerShare": 7.526, "ebitda": -249336992, "totalDebt": 87761000, "quickRatio": 7.226, "currentRatio": 7.53, "totalRevenue": 47072000, "debtToEquity": 10.503, "revenuePerShare": 0.627, "returnOnAssets": -0.20652, "returnOnEquity": -0.36382, "grossProfits": 47072000, "freeCashflow": -181843376, "operatingCashflow": -194500992, "revenueGrowth": -0.846, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -10.921689, "financialCurrency": "USD", "symbol": "KYMR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1740778838, "regularMarketTime": 1740776400, "exchange": "NGM", "messageBoardId": "finmb_542085131", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "shortName": "Kymera Therapeutics, Inc.", "longName": "Kymera Therapeutics, Inc.", "regularMarketChangePercent": 3.636365, "regularMarketPrice": 31.35, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1598016600000, "postMarketChangePercent": 0.00351049, "postMarketPrice": 31.3511, "postMarketChange": 0.00110054, "regularMarketChange": 1.1000004, "regularMarketDayRange": "29.16 - 31.49", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 509728, "fiftyTwoWeekLowChange": 2.1900005, "fiftyTwoWeekLowChangePercent": 0.0751029, "fiftyTwoWeekRange": "29.16 - 53.27", "fiftyTwoWeekHighChange": -21.92, "fiftyTwoWeekHighChangePercent": -0.41148865, "fiftyTwoWeekChangePercent": -28.990608, "earningsTimestamp": 1740657600, "earningsTimestampStart": 1746016200, "earningsTimestampEnd": 1746448200, "earningsCallTimestampStart": 1740663000, "earningsCallTimestampEnd": 1740663000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.98, "epsForward": -3.11, "epsCurrentYear": -3.50652, "priceEpsCurrentYear": -8.940488, "fiftyDayAverageChange": -7.9904003, "fiftyDayAverageChangePercent": -0.20310928, "twoHundredDayAverageChange": -10.306299, "twoHundredDayAverageChangePercent": -0.24741274, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-08-21", "averageAnalystRating": "1.5 - Buy", "cryptoTradeable": false, "displayName": "Kymera Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-03-01"}]